These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 38100005)
1. Estimating health state utilities in Duchenne muscular dystrophy using the health utilities index and EQ-5D-5L. Audhya IF; Szabo SM; Bever A; O'Sullivan F; Malone DC; Feeny D; Neumann P; Iannaccone ST; Jayasinghe P; Gooch KL J Patient Rep Outcomes; 2023 Dec; 7(1):132. PubMed ID: 38100005 [TBL] [Abstract][Full Text] [Related]
2. Exploring the relationship between North Star Ambulatory Assessment and Health Utilities Index scores in Duchenne muscular dystrophy. Audhya I; Rogula B; Szabo SM; Feeny D; Bolatova T; Gooch K Health Qual Life Outcomes; 2023 Jul; 21(1):76. PubMed ID: 37468890 [TBL] [Abstract][Full Text] [Related]
3. Factors associated with the health-related quality of life among people with Duchenne muscular dystrophy: a study using the Health Utilities Index (HUI). Szabo SM; Audhya IF; Rogula B; Feeny D; Gooch KL Health Qual Life Outcomes; 2022 Jun; 20(1):93. PubMed ID: 35690783 [TBL] [Abstract][Full Text] [Related]
4. Characterizing health state utilities associated with Duchenne muscular dystrophy: a systematic review. Szabo SM; Audhya IF; Malone DC; Feeny D; Gooch KL Qual Life Res; 2020 Mar; 29(3):593-605. PubMed ID: 31811595 [TBL] [Abstract][Full Text] [Related]
5. Assessing validity of the EQ-5D-5L proxy in children and adolescents with Duchenne muscular dystrophy or spinal muscular atrophy. Xu RH; Dai Y; Ng SSM; Tsang HWH; Zhang S; Dong D Eur J Health Econ; 2024 Feb; 25(1):103-115. PubMed ID: 36809586 [TBL] [Abstract][Full Text] [Related]
6. Cataloging health state utility estimates for Duchenne muscular dystrophy and related conditions. Do LA; Sedita LE; Klimchak AC; Salazar R; Kim DD Health Qual Life Outcomes; 2024 Sep; 22(1):72. PubMed ID: 39218902 [TBL] [Abstract][Full Text] [Related]
7. Assessing the Appropriateness of the EQ-5D for Duchenne Muscular Dystrophy: A Patient-Centered Study. Crossnohere NL; Fischer R; Lloyd A; Prosser LA; Bridges JFP Med Decis Making; 2021 Feb; 41(2):209-221. PubMed ID: 33463405 [TBL] [Abstract][Full Text] [Related]
8. Deriving a Preference-Based Measure for People With Duchenne Muscular Dystrophy From the DMD-QoL. Rowen D; Powell P; Mukuria C; Carlton J; Norman R; Brazier J Value Health; 2021 Oct; 24(10):1499-1510. PubMed ID: 34593174 [TBL] [Abstract][Full Text] [Related]
9. A comparison of the EuroQol-5D and the Health Utilities Index mark 3 in patients with rheumatic disease. Luo N; Chew LH; Fong KY; Koh DR; Ng SC; Yoon KH; Vasoo S; Li SC; Thumboo J J Rheumatol; 2003 Oct; 30(10):2268-74. PubMed ID: 14528528 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer. Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439 [TBL] [Abstract][Full Text] [Related]
11. Assessing health-related quality-of-life in patients with symptomatic obstructive hypertrophic cardiomyopathy: EQ-5D-based utilities in the EXPLORER-HCM trial. Xie J; Wang Y; Xu Y; Fine JT; Lam J; Garrison LP J Med Econ; 2022; 25(1):51-58. PubMed ID: 34907813 [TBL] [Abstract][Full Text] [Related]
12. A review of the psychometric properties of generic utility measures in multiple sclerosis. Kuspinar A; Mayo NE Pharmacoeconomics; 2014 Aug; 32(8):759-73. PubMed ID: 24846760 [TBL] [Abstract][Full Text] [Related]
13. Relative efficiency of the EQ-5D, HUI2, and HUI3 index scores in measuring health burden of chronic medical conditions in a population health survey in the United States. Luo N; Johnson JA; Shaw JW; Coons SJ Med Care; 2009 Jan; 47(1):53-60. PubMed ID: 19106731 [TBL] [Abstract][Full Text] [Related]
14. A qualitative study to understand the Duchenne muscular dystrophy experience from the parent/patient perspective. Brown V; Merikle E; Johnston K; Gooch K; Audhya I; Lowes L J Patient Rep Outcomes; 2023 Dec; 7(1):129. PubMed ID: 38085412 [TBL] [Abstract][Full Text] [Related]
15. Measurement of Health-Related Quality of Life in Individuals With Rare Diseases in China: Nation-Wide Online Survey. Xu RH; Ng SSM; Luo N; Dong D; Zhang S JMIR Public Health Surveill; 2023 Oct; 9():e50147. PubMed ID: 37906229 [TBL] [Abstract][Full Text] [Related]
17. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe. Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G; Eur J Health Econ; 2016 Apr; 17 Suppl 1():19-29. PubMed ID: 27038625 [TBL] [Abstract][Full Text] [Related]
18. Quantifying the burden of caregiving in Duchenne muscular dystrophy. Landfeldt E; Lindgren P; Bell CF; Guglieri M; Straub V; Lochmüller H; Bushby K J Neurol; 2016 May; 263(5):906-915. PubMed ID: 26964543 [TBL] [Abstract][Full Text] [Related]
19. Estimating preference-based EQ-5D health state utilities or item responses from neuropathic pain scores. Gu NY; Bell C; Botteman MF; Ji X; Carter JA; van Hout B Patient; 2012; 5(3):185-97. PubMed ID: 22765255 [TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms. McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]